Lilotomab (HH1) is a murine anti-CD37 antibody with anti-tumor activity. It can be used as a synthetic anti-CD37 antibody-radionuclide coupling (177Lu-lilotomab satetraxetan).
Purity:
95.00%
CAS Number:
[1453362-55-4]
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted